SCHEMBL255887

SCHEMBL255887

CN(C)C/C=C/C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL692137 1.00
SCHEMBL3706927 1.00
Hydrochloric Acid SCHEMBL665365 0.97 TSHR (0.44)
Hydrochloric Acid SCHEMBL665366 0.97 TSHR (0.44)
Hydrochloric Acid SCHEMBL20305534 0.95 TSHR (0.42)
Methylene Chloride SCHEMBL28375080 0.91 TSHR (0.39)
SCHEMBL2607971 0.86
Maleic Acid SCHEMBL1756125 0.84 TSHR (0.38)
Maleic Acid SCHEMBL22367552 0.84 TSHR (0.38)
Maleic Acid SCHEMBL30806194 0.84 TSHR (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4745152-A2 PEPTIDES BINDING TO BFL-1 Dana-Farber Cancer Institute, Inc. (US) 2026-05-20 EP claimed
EP-3341008-B1 PEPTIDES BINDING TO BFL-1 DANA FARBER CANCER INST INC (US) 2026-04-15 EP claimed
CN-119707574-A High-magnesium-content compound fertilizer and preparation method and application thereof 安徽司尔特化肥科技有限公司 2025-03-28 CN claimed
CN-116041337-A Preparation method of afatinib and maleate thereof 天津玖合成城企业管理合伙企业(有限合伙) 2023-05-02 CN claimed
CN-111875539-B Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 苏中药业集团股份有限公司 2022-06-21 CN claimed
EP-3787629-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES Kinnate Biopharma Inc. (US) 2021-03-10 EP claimed
CN-107325082-B Preparation method of high-purity afatinib 扬子江药业集团有限公司 2021-03-02 CN claimed
US-20210053969-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES KINNATE BIOPHARMA INC. 2021-02-25 US claimed
CN-111875539-A Preparation method of EGFR (epidermal growth factor receptor) molecular targeted antitumor drug 江苏苏中药业集团股份有限公司 2020-11-03 CN claimed
US-10550107-B2 Process for the preparation of N-[4-[(3-chloro-4-fluoro phenyl) amino]-7-[[(3s-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethyl amino)-(2E)-2-butenamide (2Z)-2-butenedioate (1:2) and its polymorphs thereof MSN LABORATORIES PRIVATE LIMITED (IN) 2020-02-04 US claimed
EP-1171440-A1 SUBSTITUTED-3-CYANO-[1.7],[1.5], AND [1.8]-NAPHTHYRIDINE INHIBITORS OF TYROSINE KINASES American Cyanamid Company (US) 2002-01-16 EP claimed
WO-2001068186-A2 USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS AMERICAN CYANAMID COMPANY (US) 2001-09-20 WO claimed
US-6251912-B1 Substituted quinazoline derivatives AMERICAN CYANAMID COMPANY 2001-06-26 US claimed
WO-2001012227-A1 NSAID AND EFGR KINASE INHIBITOR CONTAINING COMPOSITION FOR THE TREATMENT OR INHIBITION OF COLONIC POLYPS AND COLORECTAL CANCER AMERICAN CYANAMID COMPANY (US) 2001-02-22 WO claimed
WO-2000066583-A1 SUBSTITUTED 3-CYANO-[1.7], [1.5], AND [1.8]-NAPHTHYRIDINE INHIBITORS OF TYROSINE KINASES AMERICAN CYANAMID COMPANY (US) 2000-11-09 WO claimed
EP-1000039-A1 SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS American Cyanamid Company (US) 2000-05-17 EP claimed
EP-0973746-A1 SUBSTITUTED 3-CYANO QUINOLINES American Cyanamid Company (US) 2000-01-26 EP claimed
US-6002008-A Substituted 3-cyano quinolines AMERICAN CYANAMID COMPANY 1999-12-14 US claimed
WO-1999009016-A1 SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS TYROSINE KINASE INHIBITORS AMERICAN CYANAMID COMPANY (US) 1999-02-25 WO claimed
WO-1998043960-A1 SUBSTITUTED 3-CYANO QUINOLINES AMERICAN CYANAMID COMPANY (US) 1998-10-08 WO claimed